Skip to main content
WELLBIOTEC CO.,LTD logo

WELLBIOTEC CO.,LTD — Investor Relations & Filings

Ticker · 010600 ISIN · KR7010600005 KO Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2026-05-20 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 010600

About WELLBIOTEC CO.,LTD

http://www.wellbiotec.com/?language=eng

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(감자결정)
Share Issue/Capital Change Classification · 92% confidence The document is a Korean material event report (‘주요사항보고서’) announcing and correcting details of a capital reduction decision (‘감자 결정’). It does not contain full financial statements but instead outlines the specifics of the share reduction (capital change) and amends the previously filed announcement. This matches the Share Issue/Capital Change category (SHA).
2026-05-20 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 93% confidence The document is the official Korean-language quarterly report (분기보고서) of 웰바이오텍(주) for the first quarter of fiscal 2026 (2026-01-01 to 2026-03-31). It contains full financial statements—balance sheet, income statement, cash flow statement—and detailed notes, consistent with an Interim/Quarterly Report. This matches the definition of filing category 16: Interim / Quarterly Report (IR). Q1 2026
2026-05-15 Korean
[기재정정]주요사항보고서(감자결정)
Regulatory Filings
2026-04-30 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) and contains detailed sections including company overview, history, capital changes, and business operations for the 51st fiscal year (2025). This is a standard Korean Annual Report (10-K equivalent) filed with the Financial Supervisory Service and the Korea Exchange. It contains comprehensive financial and operational information, not just an announcement or a summary. FY 2025
2026-03-31 Korean
주요사항보고서(감자결정)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission (금융위원회) regarding a 'Capital Reduction Decision' (감자 결정). This involves a change in the company's capital structure, specifically a reduction of capital through share cancellation. According to the provided filing categories, announcements regarding capital changes, share issues, or capital structure adjustments fall under the 'Share Issue/Capital Change' (SHA) category.
2026-03-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by a major shareholder (Metafreeze and related parties) in Wellbiotech Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2026-01-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.